These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35038564)

  • 1. Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicology.
    Black MB; Stern A; Efremenko A; Mallick P; Moreau M; Hartman JK; McMullen PD
    Toxicol In Vitro; 2022 Apr; 80():105311. PubMed ID: 35038564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment.
    Farmahin R; Williams A; Kuo B; Chepelev NL; Thomas RS; Barton-Maclaren TS; Curran IH; Nong A; Wade MG; Yauk CL
    Arch Toxicol; 2017 May; 91(5):2045-2065. PubMed ID: 27928627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects.
    Kinaret PAS; Serra A; Federico A; Kohonen P; Nymark P; Liampa I; Ha MK; Choi JS; Jagiello K; Sanabria N; Melagraki G; Cattelani L; Fratello M; Sarimveis H; Afantitis A; Yoon TH; Gulumian M; Grafström R; Puzyn T; Greco D
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32326418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver.
    Pandiri AR; Auerbach SS; Stevens JL; Blomme EAG
    Toxicol Pathol; 2023 Oct; 51(7-8):470-481. PubMed ID: 38288963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicogenomics - What added Value Do These Approaches Provide for Carcinogen Risk Assessment?
    Schmitz-Spanke S
    Environ Res; 2019 Jun; 173():157-164. PubMed ID: 30909101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets.
    Burgoon LD; Zacharewski TR
    Toxicol Sci; 2008 Aug; 104(2):412-8. PubMed ID: 18441342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicogenomics in Environmental Science.
    Brinke A; Buchinger S
    Adv Biochem Eng Biotechnol; 2017; 157():159-186. PubMed ID: 27864593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Variability and Uncertainty Associated with Transcriptomic Dose-Response Modeling.
    Ewald JD; Basu N; Crump D; Boulanger E; Head J
    Environ Sci Technol; 2022 Nov; 56(22):15960-15968. PubMed ID: 36268973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
    Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
    PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide.
    LaRocca J; Costa E; Sriram S; Hannas BR; Johnson KJ
    Regul Toxicol Pharmacol; 2020 Jun; 113():104655. PubMed ID: 32268158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rat Liver Transcriptomic Point of Departure Predicts a Prospective Liver or Non-liver Apical Point of Departure.
    Johnson KJ; Auerbach SS; Costa E
    Toxicol Sci; 2020 Jul; 176(1):86-102. PubMed ID: 32384157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMDExpress Data Viewer - a visualization tool to analyze BMDExpress datasets.
    Kuo B; Francina Webster A; Thomas RS; Yauk CL
    J Appl Toxicol; 2016 Aug; 36(8):1048-59. PubMed ID: 26671443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic transcriptional dose-response analysis of male and female Fischer rats exposed to hexabromocyclododecane.
    Farmahin R; Gannon AM; Gagné R; Rowan-Carroll A; Kuo B; Williams A; Curran I; Yauk CL
    Food Chem Toxicol; 2019 Nov; 133():110262. PubMed ID: 30594549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
    Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining toxicogenomic data for dose-responsive pathways: implications in advancing next-generation risk assessment.
    Barutcu AR; Black MB; Nong A
    Front Toxicol; 2023; 5():1272364. PubMed ID: 38046401
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of evidence from high-throughput screening and transcriptomic data in human health risk assessments.
    Mezencev R; Subramaniam R
    Toxicol Appl Pharmacol; 2019 Oct; 380():114706. PubMed ID: 31400414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
    Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.